Skip to main content
Oxidative Medicine and Cellular Longevity logoLink to Oxidative Medicine and Cellular Longevity
. 2017 Sep 24;2017:3575348. doi: 10.1155/2017/3575348

Corrigendum to “Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model”

Paola Songia 1,2, Benedetta Porro 1, Mattia Chiesa 1, Veronika Myasoedova 1, Francesco Alamanni 1,3, Elena Tremoli 1, Paolo Poggio 1,✉
PMCID: PMC5632913  PMID: 29147460

In the article titled “Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model” [1], references [2, 3] should have been included as references 24 and 25 in the original article.

Accordingly, in the introduction section, the text reading “Echocardiographically, MVP is defined as a single or bileaflet prolapse, at least 2 mm beyond the long-axis annular plane, while the assessment of valve regurgitation takes into account the effective regurgitant orifice area (EROA) [2]” should be changed to “Echocardiographically, MVP is defined as a single or bileaflet prolapse, at least 2 mm beyond the long-axis annular plane, while the assessment of the severity of MR relies on several parameters according to the current recommendations [24, 25].”

Additionally, the Acknowledgments section should be updated as follows:

“The authors thank the entire Cardiac Surgery Unit at Centro Cardiologico Monzino for the clinical data and blood collection. The authors also would like to thank Dr. Paola Gripari for patient evaluation and critical review. This work was supported by the Fondazione Gigi e Pupa Ferrari ONLUS and the Italian Ministry of Health [RC2015-BIO30-2613051 to Centro CardiologicoMonzino].”

References

  • 1.Songia P., Porro B., Chiesa M., et al. Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. Oxidative Medicine and Cellular Longevity. 2017;2017:6. doi: 10.1155/2017/6838921.6838921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zoghbi W. A., Adams D., Bonow R. O., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography. 2017;30(4):303–371. doi: 10.1016/j.echo.2017.01.007. [DOI] [PubMed] [Google Scholar]
  • 3.Nishimura R. A., Otto C. M., Bonow R. O., et al. 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440–2492. doi: 10.1161/CIR.0000000000000029. [DOI] [PubMed] [Google Scholar]

Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Wiley

RESOURCES